Get started
Work

Antiphospholipid Antibodies and Atrial Fibrillation: Clinical Implications and the TaPL-AF Study Design

Year: 2026
Type: article
DOI: 10.1055/a-2899-3848
Authors: Bassil Bacare, Syed Bukhari, Nathan W. Watson, Julia Malejczyk, Christopher Amalan, Sina Rashedi, Mariana B. Pfeferman, Brittany Weber, Siddharth Patel, Christian Ruff, Yogendra Kanthi, Mary Cushman, Jason Knight, Samuel Z. Goldhaber, Karen Costenbader, Ryan Mize, Sacha Uljon, Christine M. Albert, Gregory Y. H. Lip, Harlan M. Krumholz, Gregory M. Piazza, Behnood Bikdeli
Institutions: Brigham and Women's Hospital, Harvard University, Johns Hopkins University, National Heart, Lung, and Blood Institute, University of Vermont, University of Michigan, Massachusetts General Hospital, Mass General Brigham, University of Liverpool, Yale University
Language: English
Subfield: Rheumatology
Field: Medicine
Open Access status: closed
OpenAlex ID: W7165837688
FWCI:
Cites: 59
Cited by:
Related to: